Wed, Oct 1, 2014, 2:00 AM EDT - U.S. Markets open in 7 hrs 30 mins


% | $
Quotes you view appear here for quick access.

Crocs, Inc. Message Board

jennifer_jkarim 21 posts  |  Last Activity: Sep 23, 2014 3:29 PM Member since: May 1, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • jennifer_jkarim by jennifer_jkarim Sep 23, 2014 3:29 PM Flag

    Mr. Cartwright,

    When shares are sold at a discount to the market price, everyone loses.
    Had ITEM Medical bought 500,000 shares at .40 ( a small premium), the pps would have gone up.
    ITEM would have made money and shareholders would have profited.

    Selling the shares at .30 tells the markets that the stock is not worth more than .30.
    If the Company is selling shares at .30, why would anyone pay more?

    Please end the cycle of selling shares below market price.
    It only serves to push the stock price lower and it benefits no one.

    Sell shares at a premium and the stock price will go up.
    If the investor is not convinced, guarantee reimbursement of any losses on the shares for a period of time.
    When an investor pays a premium, it signals to the markets that the stock is undervalued and the stock price will rise.

    In the alternative, you can raise funds by issuing rights to shareholders.
    It's non-dilutive.



  • Reply to

    email to GC sent 9/19

    by jennifer_jkarim Sep 23, 2014 3:19 PM
    jennifer_jkarim jennifer_jkarim Sep 23, 2014 3:26 PM Flag


    The stock price was over $2 in 2004. Now with the markets at record highs, GTHP is nearing record lows.
    What expectations should shareholders have for the balance of the year? Will you be offering shares and free warrants at continually lower discounted prices or will you alter the decade long downward spiral?



  • jennifer_jkarim by jennifer_jkarim Sep 23, 2014 3:19 PM Flag

    Mr. Cartwright,

    In October 2013, the stock was trading in the .60s when the Company announced a repricing of the outstanding .65 warrants to .40. The stock price promptly dropped into the .40s.

    In September of this year, the stock was near .40 when the Company announced the "investment" by a Turkish distributor at .30 plus free warrants. The stock price promptly dropped to .30.
    Selling a dollar for .75 is not an investment, it's highway robbery.

    If ITEM Medical tried buying 650,000 shares on the open market, their average price would have been closer to .50. So, if they were interested in making an investment, .50 plus the free warrants would have been a fair price. The Company raised $200,000 but shareholders lost $10 million on the price drop from .45 to .30.

    The stock price is not a reflection of the value of the Company. In the discussions with ITEM Medical, did you make a case that the Company is worth $1 per share and that you'd sell them shares at a 50% discount, or .50 plus free warrants?

    The stock closed at .375 today. As a stockholder, I would be thrilled to buy 650,000 shares at .40 ( a premium to the market price), if 325,000 warrants were included.

    A S1 was recently filed for the sale of up to 45 million shares. Will the next sale of shares be at .20?
    Will the downward spiral ever end?

    Paying fees to Olympus for massive dilution of shareholders is preferable to a non-dilutive rights offering to shareholders? You are supposed to be be working for shareholders, not against them.

    The stock should spike on the anticipated FDA approval, which will trigger the exercise of warrants. Is this registration just precautionary, in the event that FDA approval is not received, or will you be pounding the depressed stock price even lower with more discounted offerings before the FDA decision?

    I was hopeful that, with your connections, you would be able to secure funds via an investment, distribution agreement or loan from a large medical device company.

  • Reply to

    Response to Email:

    by jennifer_jkarim Aug 20, 2014 12:42 PM
    jennifer_jkarim jennifer_jkarim Aug 20, 2014 1:15 PM Flag

    True, but I just threw it out there. He could answer that insiders are not selling.

    I'm just pushing for a well worded PR:

    That there is no known reason for the price drop.
    A robust second half is on target.
    No new shares are being sold, the amended prospectus was just an update to an old prospectus.
    Maybe a mention of new orders , new distributors, plans for new territories ........

    ........... something to that effect.

  • Reply to

    Response to Email:

    by jennifer_jkarim Aug 20, 2014 12:42 PM
    jennifer_jkarim jennifer_jkarim Aug 20, 2014 12:44 PM Flag

    My follow up was:

    Thanks Gene.

    Regarding the price drop on large volume:
    I'm guessing that investors saw the prospectus and got spooked, thinking that it's new dilution.
    The large block sales also points to individuals listed in the original prospectus as being the sellers.
    Is it the former or the latter?

    Another possibility is that a hedge fund saw the prospectus and thought that a 44M share offering is imminent and started shorting the stock?

    Is a PR necessary to clarify the situation considering that the stock took a 20%+ hit?


  • jennifer_jkarim by jennifer_jkarim Aug 20, 2014 12:42 PM Flag


    We agree that there may have been some unfortunate confusion regarding the Prospectus which we put out on Monday, following our earnings call last Thursday.

    The Prospectus was not a registration of additional shares, but only an update of the existing prospectus in order to add our Q2 10-Q to the disclosure information.

    We have issued Prospectuses like this for each 10-Q and for each material 8-k. The reason that we issue these Prospectuses is always the same: to add the new disclosure to the S-1's disclosure information.

    Unfortunately, since we are a S-1 filer, (and not an S-3 filer), we have to update our S-1 information manually as described, by issuing new Prospectuses.
    No new shares were added, no previously registered shares were deleted, no "breakdown" changed.

    In the future, we plan to put some very clear statement at the beginning of the Prospectus which states that "there is no registration or issuance of additional shares." Hopefully, saying something like this, clearly at the beginning of the document should help prevent any future confusion.

    Let me know if you have any questions.

  • Reply to

    Email to GC on 8/19

    by jennifer_jkarim Aug 20, 2014 12:09 PM
    jennifer_jkarim jennifer_jkarim Aug 20, 2014 12:31 PM Flag

    Could it be that a hedge fund saw the prospectus and thought that a 44M share offering is imminent and started shorting the stock?

    Hopefully, Gene will provide some insight.
    A PR might be necessary.

  • Reply to

    Email to GC on 8/19

    by jennifer_jkarim Aug 20, 2014 12:09 PM
    jennifer_jkarim jennifer_jkarim Aug 20, 2014 12:24 PM Flag

    I'm guessing that investors saw the prospectus and got spooked, thinking that it's new dilution.
    The large block sales also points to individuals listed in the original prospectus as being the sellers.
    Is it the former or the latter?

  • jennifer_jkarim by jennifer_jkarim Aug 20, 2014 12:09 PM Flag

    Hi Gene,

    The stock price got hammered yesterday. I'm guessing that it is related to the amended prospectus that was filed yesterday showing the sale of 44 million shares, or nearly 60% dilution.

    The original prospectus filed in May showed the break down of the shares, that 27M of the 44M were warrants exercisable at higher prices and not new dilution. This amended prospectus did not specify what was being sold.

    Is that the reason for the price decline or have the shares been registered and the shareholders/funds/insiders are now able to sell and are selling? Can you clarify to shareholders what is going on with this Amended Prospectus?

    John Edwin Imhoff ..... ...................................13,913,499
    Dolores Maloof ............................................... 5,666,311
    David B. Musket .............................................. 2,958,430
    Alpha Capital Anstalt ...................................... 2,842,370
    Capital Ventures International ...................... 1,705,421
    Hanover Holdings I, LLC ............................... 3,102,432
    Ronald Wilson Hart ........................................ 1,882,717
    Cranshire Capital Master Fund, Ltd. ........... 1,136,950
    Easton Hunt Capital Partners, LP ................ 1,061,663

    (The list continues, it is long. I'm leaving out the others in this message).

    GC's response this morning:
    "I'll get back to you, hopefully today, on your question."

    (It seems that nobody knows what is going on. I would think that the 44M shares are just being registered and are already part of the 75M shares outstanding, except for the 27M warrants, which would come into play when exercised.)

  • Reply to

    If you believe this is going down further

    by brad_210000 Aug 18, 2014 1:28 PM
    jennifer_jkarim jennifer_jkarim Aug 18, 2014 1:40 PM Flag

    Definition of a loser: throwing good money after bad.
    Never try to catch a falling knife.

    Buy stocks that are in an uptrend, not those that are tanking.
    Wait for a high volume shake out day or buy after a stock languishes near the bottom for a few months and then starts to break out.

    You are exhibiting your foolishness with this post.

  • Reply to

    Switch to GTHP ..... CC Tomorrow

    by gthp10bagger Aug 13, 2014 11:06 AM
    jennifer_jkarim jennifer_jkarim Aug 13, 2014 4:55 PM Flag

    I'm in. Got 3 shares of GTHP for each SIGA share. Couldn't be happier to get out of this nightmare.

  • jennifer_jkarim jennifer_jkarim Aug 8, 2014 5:15 PM Flag

    GC has always replied in the past.
    His non-response confirms my suspicion.
    If an offering was not placed, he could have said so.
    He can't disclose that a placement agent is working the offering, since it's nonpublic information.
    If I'm right, the stock will continue to get hammered.

  • jennifer_jkarim jennifer_jkarim Aug 8, 2014 5:05 PM Flag

    You give a commitment to the underwriter to buy a specific allotment of shares and then start shorting until you reach your allocable amount of shares. The shares from the offering are used to cover the short position. It's a risk free guaranteed profit for the hedgies to spruce up their annualized returns. You can short before, during and after the offering.

  • Mr. Cartwright,

    The stock price is tanking as if though you shopped an offering with the Wall Street Vultures, and the hedgies are now shorting the stock. I hope you are not doing an offering at 10% or 15% below the stock price on the date of the offering, thereby inviting the hedgies to short the stock; to fill their pockets while they empty the shareholders pockets, and then to add insult to injury, you will give them a parting gift of freebie warrants. Please tell me that isn't the case.


  • jennifer_jkarim by jennifer_jkarim Aug 5, 2014 3:30 PM Flag

    But why let common sense get in the way of an emotional attachment to a dog that bites the owners hand?

  • jennifer_jkarim jennifer_jkarim Jul 28, 2014 9:57 PM Flag

    Do you think that after having the 16M increase to the prior incentive plan approved, that the shares won't be doled out? It's a done deal - approved!

  • jennifer_jkarim jennifer_jkarim Jul 28, 2014 9:29 PM Flag

    It's not the exchange and it's not the company.
    It's who is running the company.

    I own shares in GTHP which trades on the OTC.
    The new CEO, Gene Cartwright who was formerly with GE Diagnostics and Abbott Healthcare answers my emails, usually within a few minutes, if he is in the office.

    The corporate culture starts at the top.
    You can have sleaze bags running a company who have little regard for shareholders or management that are responsive to shareholders.

  • Reply to

    GTHP and ONCS are About the Same pps

    by zero.risk13 Jul 28, 2014 11:54 AM
    jennifer_jkarim jennifer_jkarim Jul 28, 2014 12:28 PM Flag

    "A pap smear can cost you anywhere between $50 to $200."
    So the market is between $3B and $12B in the US, and larger overseas.

    GTHP's technology is more accurate than the pap smear and produces instant test results.
    GTHP will dominate the market.
    Sales will be increasing for decades.

    They are also working on an esophagial cancer scan.

  • Reply to

    For those asking and/or wondering

    by brotherbear44 Jul 16, 2014 6:14 PM
    jennifer_jkarim jennifer_jkarim Jul 16, 2014 8:05 PM Flag

    The stock to move the proceeds into is GTHP.
    A PMA will be filed with the FDA this month.
    The pps should get a nice bump then.
    HPV cervical cancer scans are a huge market.
    Over 60 million pap smear tests are taken in the US alone.
    GTHP just received marketing approval in Mexico this month and in the EU, Canada and Singapore earlier.
    International sales are just ramping up and will accelerate each quarter.
    GTHP will get revenues from the sale of the scanners plus recurring revenues from the disposables used in each scan which carry 90% profit margins.

    The market cap is only $35M .... you can't go wrong.
    There is no need to wait 5 years or more for maybe, possibly approval.
    GTHP is already selling product.
    There are lots of catalysts.
    An esophageal cancer scan will follow and then one for lung cancer.

    GTHP's patent protected biophtonic scan is more accurate than conventional tests and it produces instant test results.

  • jennifer_jkarim jennifer_jkarim Jul 15, 2014 7:59 PM Flag

    GTHP - market cap $35M.

12.58-0.17(-1.33%)Sep 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Cyber-Ark Software Ltd.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT
eBay Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT
Civeo Corporation
NYSETue, Sep 30, 2014 4:04 PM EDT